Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(22%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
3
33%
Ph phase_4
2
22%
Ph phase_2
4
44%

Phase Distribution

0

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
4(44.4%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(3)
Other(4)

Detailed Status

unknown3
Completed3
Suspended1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (44.4%)
Phase 42 (22.2%)
N/A3 (33.3%)

Trials by Status

suspended111%
active_not_recruiting111%
recruiting111%
unknown333%
completed333%

Recent Activity

2 active trials
Showing 5 of 9
recruitingnot_applicable

Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes

NCT05642715
active_not_recruitingphase_2

Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis

NCT06058299
completedphase_2

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

NCT03338621
suspendedphase_2

Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide

NCT04694586
completedphase_4

Comparison of Metal on Metal Total Hip Arthroplasty and Metal on Metal Total Hip Resurfacing.

NCT04516239
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05642715Not Applicable

Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes

Recruiting
NCT06058299Phase 2

Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis

Active Not Recruiting
NCT03338621Phase 2

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

Completed
NCT04694586Phase 2

Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide

Suspended
NCT04516239Phase 4

Comparison of Metal on Metal Total Hip Arthroplasty and Metal on Metal Total Hip Resurfacing.

Completed
NCT04000126Not Applicable

Pupillometry - Future of Objective Pain Reaction Measurement While Unconscious

Completed
NCT01570166Not Applicable

Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma

Unknown
NCT02452853Phase 2

HR Combined With FOLFOX4 for HCC With PVTT

Unknown
NCT01570075Phase 4

Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan Criteria

Unknown

All 9 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9